Henry G. Grabowski

Economics and Econometrics · 2003–2016

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

Whom Henry G. Grabowski trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. DiMasi

Who trusts Henry G. Grabowski overall

  1. J. DiMasi
  2. Yuanqi Du
  3. Ram Mudambi
  4. B. Munos

Papers from Henry G. Grabowski's perspective

Ordered by how strongly the researchers Henry G. Grabowski trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The price of innovation: new estimates of drug development costs.
  2. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
  3. The druggable genome (Nature reviews. Drug discovery)
  4. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia (Nature Genetics)
  5. PCSK9: a convertase that coordinates LDL catabolism Published, JLR Papers in Press, November 19, 2008. (Journal of Lipid Research)
  6. The Black Swan: The Impact of the Highly Improbable
  7. Seeing What's Next: Using the Theories of Innovation to Predict Industry Change
  8. Estimating the cost of new drug development: is it really 802 million dollars?
  9. How to improve R&D productivity: the pharmaceutical industry's grand challenge
  10. A Comparison of U.S. and European University-Industry Relations in the Life Sciences

Their papers